Luxdegalutamide is an orally active PROTAC that targets the androgen receptor (AR) for degradation, including resistant mutants such as T878, H875, and L702. Its structural design facilitates the study of mechanisms related to castration-resistant prostate cancer. Reagent-grade; for laboratory research purposes only.
Products > PROTAC, Molecular glue > Degraders
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye